Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure

How to buy Liminal BioSciences stock

Learn how to easily invest in Liminal BioSciences stock.

Liminal BioSciences Inc is a biotechnology business based in the US. Liminal BioSciences shares (LMNL) are listed on the NASDAQ and all prices are listed in US Dollars.

How to buy shares in Liminal BioSciences

  1. Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – LMNL – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.
Client disclaimer: US Brokerage services through eToro USA Securities Inc, member of FINRA, SIPC. Crypto assets through eToro USA LLC.

Liminal BioSciences stock price (NASDAQ: LMNL)

Use our graph to track the performance of LMNL stocks over time.

Liminal BioSciences shares at a glance

Information last updated 2022-09-27.
Latest market close$0.42
52-week range$0.37 - $2.38
50-day moving average $0.48
200-day moving average $0.72
Wall St. target price$1.05
PE ratio 0.7935
Dividend yield $0 (0%)
Earnings per share (TTM) $0.57

Buy Liminal BioSciences shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
1 - 7 of 7
Name Product Asset types Stock trade fee Minimum deposit Signup bonus
SoFi Invest
Stocks, ETFs, Cryptocurrency
$0
$0
$10 - $100
when you open an account and place a first crypto trade of $50 - $5,000+
A free way to invest in most equities.
eToro
Stocks, ETFs, Cryptocurrency
$0
$10
8%-12% of your deposit
when you sign up and deposit at least $50. T&Cs apply.
Trade stocks in the app or online with $0 commissions. Not available in NY, NV, MN, TN, and HI.
Public
Stocks, ETFs, Cryptocurrency
$0
$0
Receive a free stock slice worth between $3–$300
when you sign up for an account and deposit at least $20.
Commission-free trading in stocks and ETFs with a social networking twist.
Tastyworks
Stocks, Options, ETFs, Cryptocurrency
$0
$0
$200 in US stocks
when you open and fund an account with min. $2,000 for 3+ mos.
Trade stocks, options, ETFs and futures on mobile or desktop with this advanced platform.
JPMorgan Self-Directed Investing
Stocks, Bonds, Options, Mutual funds, ETFs
$0
$0
$125 - $625
when you open and fund an account with $25,000 - $250,000+
INVESTMENT AND INSURANCE PRODUCTS ARE: NOT A DEPOSIT • NOT FDIC INSURED • NO BANK GUARANTEE • MAY LOSE VALUE
Robinhood
Stocks, Options, ETFs, Cryptocurrency
$0
$0
Get a free stock
when you successfully sign up and link your bank account.
Make unlimited commission-free trades, plus earn 3% interest on uninvested cash in your account with Robinhood Gold.
Tradier
Stocks, Options, ETFs
$0
$0
N/A
Customize your trade platform or build your own Deep tools, charts and screens Analyzers to help you study before you trade
loading

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Liminal BioSciences stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Liminal BioSciences price performance over time

Historical closes compared with the close of $0.42 from 2022-09-29

1 week (2022-09-23) -6.67%
1 month (2022-09-01) -19.23%
3 months (2022-07-01) -20.65%
6 months (2022-03-30) -58.42%
1 year (2021-10-01) -80.91%
2 years (2020-10-01) -96.16%
3 years (2019-10-01) 10.36
5 years (2017-09-29) 1.2319

Is Liminal BioSciences stock undervalued or overvalued?

Valuing Liminal BioSciences stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Liminal BioSciences's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

Liminal BioSciences's P/E ratio

Liminal BioSciences's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 1x. In other words, Liminal BioSciences shares trade at around 1x recent earnings.

That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.

Liminal BioSciences financials

Revenue TTM $565,000
Gross profit TTM $-17,704,000
Return on assets TTM -35.02%
Return on equity TTM -461.75%
Profit margin 8610.8%
Book value $0.88
Market capitalisation $14.1 million

TTM: trailing 12 months

Liminal BioSciences share dividends

We're not expecting Liminal BioSciences to pay a dividend over the next 12 months.

Have Liminal BioSciences's shares ever split?

Liminal BioSciences's shares were split on a 1:1000 basis on 5 July 2019. So if you had owned 1000 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Liminal BioSciences shares – just the quantity. However, indirectly, the new 99900% higher share price could have impacted the market appetite for Liminal BioSciences shares which in turn could have impacted Liminal BioSciences's share price.

Liminal BioSciences share price volatility

Over the last 12 months, Liminal BioSciences's shares have ranged in value from as little as $0.365 up to $2.38. A popular way to gauge a stock's volatility is its "beta".

LMNL.US volatility(beta: 1.14)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Liminal BioSciences's is 1.1391. This would suggest that Liminal BioSciences's shares are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).

Liminal BioSciences overview

Liminal BioSciences Inc. , a clinical-stage biopharmaceutical company, focuses on the development of novel small molecule drug therapeutics for inflammatory, fibrotic, and metabolic diseases in Canada and the United Kingdom. The company's lead product candidate is fezagepras (PBI-4050), which has been completed Phase I clinical trial for the treatment of idiopathic pulmonary, liver, cardiac, or skin fibrosis with fezagepras or related derivatives and respiratory diseases. It is also developing antagonist candidate programs, including G-protein coupled receptor 84 and Oxo-eicosanoid receptor 1, which are in preclinical stage. The company was formerly known as Prometic Life Sciences Inc. and changed its name to Liminal BioSciences Inc. in October 2019.

Frequently asked questions

What percentage of Liminal BioSciences is owned by insiders or institutions?
Currently 64.127% of Liminal BioSciences shares are held by insiders and 0.94% by institutions.
When does the fiscal year end for Liminal BioSciences?
Liminal BioSciences's fiscal year ends in December.
Where is Liminal BioSciences based?
Liminal BioSciences's address is: 440 Armand-Frappier Boulevard, Laval, QC, Canada, H7V 4B4
What is Liminal BioSciences's ISIN number?
Liminal BioSciences's international securities identification number is: CA53272L1031
What is Liminal BioSciences's CUSIP number?
Liminal BioSciences's Committee on Uniform Securities Identification Procedures number is: 53272L103

More guides on Finder

Ask an Expert

You are about to post a question on finder.com:

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • finder.com is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and finder.com Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site